REFERENCES
- Abranches, P. (1984). O kala-azar da area metropolitana de Lisboa e da regiao de Alcacer do Sal. Estados sobre os reservatorios domestico e silvatico e sovre a populacao humana em risco de infeccao. Thesis, Faculdade de Ciencias Medicas, Lisbon, Portugal.
- Barker Jr, R. H. (1990). DNA probe diagnosis in parasitic infections. Experimental Parasitology, 70, 494–499.
- Budak, S., Daldal, N., Ózbel, Y. & Özbilgin, A. (1991). Investigations of vectors and reservoirs of L. donovani in Aegean region. Acta Parasitological Turcica, 15, 5–11.
- Carvalho, E. M., Reed, R. G. & Johnson Jr, W. D. (1987). Crossreactivity between T. cruzi and Leishmania antigen in the lymphocyte blastogenesis assay. Transactions of the Royal Society of Tropical Medicine and Hygiene, 81, 82–84.
- Daldal, N., Ûner, A., Yaşarol, Ş., Karacasu, F. & Yurdagül, C. (1989). The prevalence of Phlebotomus spp. in the Aegean in the Mediterranean regions. Acta Parasitologica Turcica, 13, 71–84.
- Evans, D. A. (1989). Handbook on the Isolation, Characterization and Cryopreservation of Leishmania. Geneva: World Health Organization.
- Evans, T. G., Wasconcelos, I. A. B., Lima, J. W., Teixeira, J. M., McAullife, I. T., Lopes, U. G., Pearson, R. D. & Wassconcelos, A. W. (1990). Canine visceral leishmaniasis in northeast Brazil: assessment of sérodiagnostic methods. American Journal of Tropical Medicine and Hygiene, 42, 118–123.
- Hailu, A. (1990). Pre- and post-treatment antibody levels in visceral leishmaniasis. Transactions of the Royal Society of Tropical Medicine and Hygiene, 84, 673–675.
- Harith, A. E., Kolk, A. H. J., Kager, P. A., Leeuwersburg, J., Muigai, R., Kiugu, S., Kiugu, S. & Laarman, J. (1986). A simple and economical direct agglutination test for serodiagnosis and sero-epidemiological studies of visceral leishmaniasis. Transactions of the Royal Society of Tropical Medicine and Hygiene, 80, 583–587.
- Harith, A. E., Slappendel, R. J., Reiter, I., van Knapen, F., de Korte, P., Huigen, E. & Kolk, A. H. J. (1989). Application of a DAT for detection of specific anti-Leishmania antibodies in the canine reservoir. Journal of Clinical Microbiology, 27, 2252–2257.
- Jaffe, C. L., Keren, E., Nahari, O., Rachamin, N. & Schnur, L. (1988). Canine visceral leishmaniasis at Wadi Hamam, in Israel. Transactions of the Royal Society of Tropical Medicine and Hygiene, 82, 859–863.
- Kato, T., Inoue, T., Yamamato, K., Tamura, T. & Nariuchi, H. (1992). Induction of IL-2R expression and proliferation of T-cell clones by a novel cytokine(s). Cellular Immunology, 142, 79–93.
- McMahon-Pratt, D. & David, J. R. (1982). Application of mAbs specific for Leishmania spp. In Biochemical Characterization of Leishmania, eds Chance M. L. & Walter, B. C. pp. 247–257. Geneva: World Health Organization.
- Meredith, S. E. O., Ziljstra, E. E., Schnoone, G. J., Kroone, C. C M., Van Eys, G. J. J. M., Schaeffer, K. U., El-Hassan, A. M. & Lawyer, P. G. (1993). Development and application of the PCR for the detection and identification of Leishmania parasites in clinical materials. Archives de l'Institut Pasteur de Tunis, 70, 419–431.
- Piarroux, R., Gambarelli, F., Duman, F., Fontes, M., Dunan, S., Mari, C., Toga, B. & Quilici, M. (1994). Comparation of PCR with direct examination of bone marrow aspiration, myeloculture and serology for diagnosis of VL in immunocompromised patients. Journal of Clinical Microbiology, 32, 746–749.
- Reed, S. G. & Scott, P. (1993). Cytokine response and T-cells in leishmaniasis. Current Opinion in Immunology, 5, 524–531.
- Schnur, L. F. (1982). The immunological identification and characterization of leishmanial stocks and strains with special reference of EF serotyping. In Biochemical Characterization of Leishmania, eds Chance, M. L. & Walter, B. C. pp. 25–47. Geneva: World Health Organization.
- World Health Organization (1990). Tropical Diseases. Document TDR/CTD/HH90.1. Geneva: WHO.
- World Health Organization (1993). Report of the Joint WHO/MZCP/HPI Workshop on the Epidemiology in the Diagnosis and Control of Leishmaniases in the Mediterranean Area. Document MZCP/LEISH./93.3. Geneva: WHO.